Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

…, MA Weber, L Fabry-Ribaudo, T Hu… - Journal of the American …, 2007 - jacc.org
Objectives : The purpose of this study was to determine the possible benefit of dual antiplatelet
therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic …

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis

…, EM Tuzcu, I Sipahi, AW Grasso, P Schoenhagen, T Hu… - Jama, 2007 - jamanetwork.com
ContextStatins reduce low-density lipoprotein cholesterol (LDL-C) levels and slow progression
of coronary atherosclerosis. However, no data exist describing the relationship between …

Cardiac implantable electronic device infections: presentation, management, and patient outcomes

KG Tarakji, EJ Chan, DJ Cantillon, AL Doonan, T Hu… - Heart rhythm, 2010 - Elsevier
BACKGROUND: Indications for cardiac implantable electronic devices (CIEDs) are increasing.
Although CIED infections occur infrequently, the impact of this outcome is expected to be …

Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk

…, SR Steinhubl, KH Mak, JD Easton, C Hamm, T Hu… - Circulation, 2008 - Am Heart Assoc
Background— Incomplete inhibition of platelet thromboxane generation, as measured by
elevated urinary 11-dehydro thromboxane B 2 concentrations, has been associated with an …

The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

…, JE Tcheng, RA Harrington, M Simoons, TF Hu… - Journal of the American …, 2006 - jacc.org
Objectives : We aimed to evaluate clinical outcomes among peripheral arterial disease (PAD)
patients following percutaneous coronary intervention (PCI). Background : A significant …

The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis

O Bayturan, EM Tuzcu, A Lavoie, T Hu… - Archives of internal …, 2010 - jamanetwork.com
Background The mechanism that confers adverse cardiovascular prognosis in patients with
the metabolic syndrome (MetS) remains unclear. We sought to investigate the association of …

Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant …

DJ Cantillon, KG Tarakji, T Hu, A Hsu, NG Smedira… - Heart Rhythm, 2010 - Elsevier
BACKGROUND: Pacemaker-requiring bradyarrhythmias after cardiac transplantation are
common, and rarely can lead to sudden cardiac death. Prior outcomes studies have been …

[HTML][HTML] Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study

…, A Koster, M Jurmann, DS Bhatia, T Hu… - The Journal of thoracic …, 2006 - Elsevier
OBJECTIVES: Unfractionated heparin has many shortcomings, including indirect and partial
inhibition of thrombin, antibody formation, and platelet activation. Bivalirudin, a short-acting …

Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or …

MA Iler, T Hu, S Ayyagari, TD Callahan IV… - The American journal of …, 2008 - Elsevier
Postimplant QRS narrowing may predict clinical response after cardiac resynchronization
therapy (CRT), but identification of nonresponders remains difficult. We studied the predictive …

Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome

O Bayturan, EM Tuzcu, K Uno, AJ Lavoie, T Hu… - The American journal of …, 2010 - Elsevier
Diabetes mellitus (DM) and metabolic syndrome (MS) are associated with adverse cardiovascular
outcomes. However, the extent and progression of coronary atherosclerosis for these …